Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Clinical and Paraclinical Predictive Factors for In-hospital Mortality in Adult Patients with COVID-19: A Cross-sectional Study in Iran

Author(s): Seyed Alireza Mousavi, Reyhaneh Sadat Mousavi-Roknabadi*, Fateme Nemati, Somaye Pourteimoori, Arefeh Ghorbani, Hesan Pourgholamali, Kazem Ansari, Razieh Sadat Mousavi-Roknabadi and Abdolrahim Sadeghi Yakhdani

Volume 18, Issue 2, 2022

Published on: 09 June, 2022

Page: [142 - 151] Pages: 10

DOI: 10.2174/1573398X18666220426112652

Price: $65

Abstract

Background: COVID-19, a type of coronavirus emerged in Wuhan, China in December 2019, causing an epidemic of pneumonia with unknown reasons.

Objective: This study aimed to investigate the factors affecting in-hospital mortality of patients with COVID-19 hospitalized in one of the main hospitals in central Iran.

Methods: This retrospective cross-sectional study (February-May 2020) was conducted on patients with a confirmed diagnosis of COVID-19 admitted to Yazd Shahid Sadoughi Hospital in Iran. The patients with uncompleted or missed medical files were excluded from the study. Data were extracted from the patients' medical files and then analyzed. The patients were categorized as survivors and non-survivors groups, and they were compared.

Results: Total 573 patients were enrolled and 356 (62.2%) were male. The mean±SD of age was 56.29±17.53 years, and 93 (16.23%) died. All the complications were more in non-survivors. Intensive care unit (ICU) admission was in 20.5% of the patients, which was more in non-survivors (P<0.001). The results of multivariate logistic regression test showed that pleural effusion in lung computed tomography (CT) scan (OR=0.055, P=0.019), white blood cell (WBC) (OR=1.418, P=0.022), serum albumin (OR=0.009, P<0.001), non-invasive mechanical ventilation (OR=34.351, P<0.001), and acute respiratory distress syndrome (ARDS) (OR=66.039, P=0.003) were the predictive factors for in-hospital mortality.

Conclusion: In-hospital mortality with COVID-19 was about 16%. Plural effusion in lung CT scan, increased WBC count, lower mount of serum albumin, non-invasive mechanical ventilation, and ARDS were obtained as the predictive factors for in-hospital mortality.

Keywords: COVID-19, logistic regression, prognosis factors, mortality, prevalence, coronavirus.

« Previous Next »
[1]
World Health O. WHO coronavirus disease (COVID-19) dashboard. 2021.Available from: https://covid19.who.int/
[2]
Ahn DG, Shin HJ, Kim MH, et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol 2020; 30(3): 313-24.
[http://dx.doi.org/10.4014/jmb.2003.03011] [PMID: 32238757]
[3]
Ebrahimi V, Sharifi M, Mousavi-Roknabadi RS, et al. Predictive determinants of overall survival among re-infected COVID-19 patients using the elastic-net regularized Cox proportional hazards model: A machine-learning algorithm. BMC Public Health 2022; 5: 10.
[http://dx.doi.org/10.21203/rs.3.rs-371941/v1]
[4]
Sharifi M, Khademian MH, Mousavi-Roknabadi RS, Ebrahimi V, Sadegh R. A New Rapid Approach for Predicting Death in Coronavirus Patients: The Development and Validation of the COVID-19 Risk-Score in Fars Province (CRSF). Iran J Public Health 2022; 51(1): 178-87.
[http://dx.doi.org/10.18502/ijph.v51i1.8310] [PMID: 35223639]
[5]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[6]
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in china: sum-mary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020; 323(13): 1239-42.
[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[7]
Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2021; 93(3): 1449-58.
[http://dx.doi.org/10.1002/jmv.26424]
[8]
Wei Y, Zeng W, Huang X, et al. Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu district, hubei province: A single-center descriptive study. BMC Infect Dis 2020; 20(1): 549.
[http://dx.doi.org/10.1186/s12879-020-05252-8]
[9]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospec-tive cohort study. Lancet 2020; 395(10229): 1054-62.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]
[10]
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844-7.
[http://dx.doi.org/10.1111/jth.14768]
[11]
Liang Y, Wang ML, Chien CS, et al. Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection. Front Immunol 2020; 11: 1022.
[http://dx.doi.org/10.3389/fimmu.2020.01022]
[12]
Zou X, Li S, Fang M, et al. Acute physiology and chronic health evaluation ii score as a predictor of hospital mortality in patients of Coronavirus Disease 2019. Crit Care Med 2020; 48(8): e657-65.
[http://dx.doi.org/10.1097/CCM.0000000000004411] [PMID: 32697506]
[13]
Dong X, Cao Y-Y, Lu X-X, et al. Eleven faces of Coronavirus Disease 2019. Allergy 2020; 75(7): 1699-709.
[http://dx.doi.org/10.1111/all.14289] [PMID: 32196678]
[14]
Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7): 1730-41.
[http://dx.doi.org/10.1111/all.14238] [PMID: 32077115]
[15]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5]
[16]
Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis. J Med Virol 2020; 92(9): 1449-59.
[http://dx.doi.org/10.1002/jmv.25822] [PMID: 32242947]
[17]
Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel Coronavirus Disease. China Med J (Engl) 2020; 133(9): 1032-8.
[http://dx.doi.org/10.1097/CM9.0000000000000775]
[18]
Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: Correlation with disease severity and short-term prognosis. Eur Radiol 2020; 30(12): 6808-17.
[http://dx.doi.org/10.1007/s00330-020-07033-y] [PMID: 32623505]
[19]
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A systematic review of imaging find-ings in 919 patients. AJR Am J Roentgenol 2020; 215(1): 87-93.
[http://dx.doi.org/10.2214/AJR.20.23034] [PMID: 32174129]
[20]
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with Coronavirus Disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis 2020; 63(3): 390-1.
[http://dx.doi.org/10.1016/j.pcad.2020.03.001]
[21]
Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: A systematic review and meta-analysis. Scand J Clin Lab Invest 2020; 80(6): 441-7.
[http://dx.doi.org/10.1080/00365513.2020.1768587]
[22]
Auld SC, Caridi-Scheible M, Blum JM, et al. ICU and ventilator mortality among critically Ill adults with Coronavirus Disease 2019. Crit Care Med 2020; 48(9): e799-804.
[http://dx.doi.org/10.1097/CCM.0000000000004457]
[23]
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically Ill patients in the seattle region - case series. N Engl J Med 2020; 382(21): 2012-2.
[http://dx.doi.org/10.1056/NEJMoa2004500]
[24]
Wang G, Wu C, Zhang Q, et al. C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis 2020; 7(5): ofaa153.
[http://dx.doi.org/10.1093/ofid/ofaa153]
[25]
Deng X, Yang J, Wang W, et al. Case fatality risk of novel coronavirus diseases 2019 in China. medRxiv 2020.2020.: 32511425.
[http://dx.doi.org/10.1101/2020.03.04.20031005]

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy